Analyst Ratings for Immunogen Inc. (IMGN)
IMGN Rating Summary
IMGN Price Target Summary
- Highest: $21.00 (Jefferies)
- Lowest: $10.00 (UBS)
- Average: $15.50
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$15.50 (-13.4%)
Avg. $ Target:
$15.50 (-13.4%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/28/2013 | Oppenheimer | Downgrade | Perform (Outperform) |
N/A (N/A) |
15.04 | 17.89 | 18.95% | Details |
| 11/9/2012 | Guggenheim | New Coverage | Neutral (N/A) |
11.00 (N/A) |
11.10 | 17.89 | 61.17% | Details |
| 9/27/2012 | UBS | New Coverage | Sell (N/A) |
10.00 (N/A) |
15.79 | 17.89 | 13.3% | Details |
| 8/24/2012 | Stifel Nicolaus | New Coverage | Hold (N/A) |
N/A (N/A) |
13.75 | 17.89 | 30.11% | Details |
| 8/22/2012 | Cowen | New Coverage | Outperform (N/A) |
N/A (N/A) |
13.52 | 17.89 | 32.32% | Details |
| 6/14/2012 | Cantor Fitzgerald | New Coverage | Hold (N/A) |
15.00 (N/A) |
14.88 | 17.89 | 20.23% | Details |
| 4/12/2012 | Roth Capital | New Coverage | Buy (N/A) |
19.00 (N/A) |
12.79 | 17.89 | 39.87% | Details |
| 7/6/2011 | Jefferies » Updated 2/25/2013 |
New Coverage | Buy (N/A) |
21.00 (17.00) |
12.21 | 17.89 | 46.52% | Details |
| 5/31/2011 | William Blair | New Coverage | Outperform (N/A) |
N/A (N/A) |
12.15 | 17.89 | 47.24% | Details |
| 5/6/2011 | Boenning & Scattergood | New Coverage | Neutral (N/A) |
N/A (N/A) |
12.66 | 17.89 | 41.31% | Details |
| 4/8/2011 | RBC Capital | Upgrade | Outperform (N/A) |
N/A (N/A) |
11.80 | 17.89 | 51.61% | Details |
| 11/8/2010 | Needham & Company » Updated 2/28/2011 |
New Coverage | Underperform (N/A) |
N/A (N/A) |
8.00 | 17.89 | 123.63% | Details |
| 10/1/2010 | JPMorgan | New Coverage | Neutral (N/A) |
N/A (N/A) |
6.27 | 17.89 | 185.33% | Details |
